Sign up to save your podcasts
Or
Share A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28
In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member.
Visit TPM E28 for highlights and links from this episode.
View all episodes
By Genialis
4.7
77 ratings
In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member.
Visit TPM E28 for highlights and links from this episode.
More shows like Talking Precision Medicine
View all
Science Weekly
419 Listeners
Hidden Brain
43,471 Listeners
Pivot
9,298 Listeners
The Daily
110,870 Listeners
The Readout Loud
316 Listeners
Biotech 2050 Podcast
61 Listeners
The Prof G Pod with Scott Galloway
5,410 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,252 Listeners
BioCentury This Week
30 Listeners
Prof G Markets
1,195 Listeners